Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysis.
Uemura M, Kikukawa H, Hashimoto Y, Uemura H, Mizokami A, Kato M, Matsushima H, Kosaka T, Nakamura M, Fukasawa S, Smith MR, Tombal B, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kakiuchi H, Akiyama M, Li R, Kuss I, Joensuu H, Suzuki H. Uemura M, et al. Among authors: hashimoto y. Cancer Med. 2024 Nov;13(21):e70029. doi: 10.1002/cam4.70029. Cancer Med. 2024. PMID: 39527466 Free PMC article. Clinical Trial.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study.
Miyakawa Y, Imada K, Ichikawa S, Uchiyama H, Ueda Y, Yonezawa A, Fujitani S, Ogawa Y, Matsushita T, Asakura H, Nishio K, Suzuki K, Hashimoto Y, Murakami H, Tahara S, Tanaka T, Matsumoto M. Miyakawa Y, et al. Among authors: hashimoto y. Int J Hematol. 2023 Mar;117(3):366-377. doi: 10.1007/s12185-022-03495-6. Epub 2022 Nov 24. Int J Hematol. 2023. PMID: 36427162 Free PMC article. Clinical Trial.
Effect of a single dose of insulin glargine/lixisenatide fixed ratio combination (iGlarLixi) on postprandial glucodynamic response in Japanese patients with type 2 diabetes mellitus: A phase I randomized trial.
Inoue M, Lorenz M, Muto H, Wesch R, Hashimoto Y. Inoue M, et al. Among authors: hashimoto y. Diabetes Obes Metab. 2019 Aug;21(8):2001-2005. doi: 10.1111/dom.13757. Epub 2019 May 24. Diabetes Obes Metab. 2019. PMID: 31050109 Free PMC article. Clinical Trial.
Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial.
Watada H, Takami A, Spranger R, Amano A, Hashimoto Y, Niemoeller E. Watada H, et al. Among authors: hashimoto y. Diabetes Care. 2020 Jun;43(6):1249-1257. doi: 10.2337/dc19-2452. Epub 2020 Apr 15. Diabetes Care. 2020. PMID: 32295808 Free PMC article. Clinical Trial.
Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! Practitioners.
Ponsioen T, Hashimoto Y, Invernizzi A, Gabrielle PH, Lavid FJ, Mehta H, Silva R, Jaross N, Squirrell D, O'Toole L, Kusenda P, Barthelmes D, Gillies M, Hunt A. Ponsioen T, et al. Among authors: hashimoto y. Clin Exp Ophthalmol. 2024 Dec 28. doi: 10.1111/ceo.14490. Online ahead of print. Clin Exp Ophthalmol. 2024. PMID: 39731402
Intragastric balloon adverse events: a comprehensive MAUDE database review.
Mohamed I, Koyi J, Abu Suilik H, Abosheiashaa H, Jaber F, Hamaad Rahman S, Singh Dahiya D, Telbany A, Ahmed OT, Hashimoto Y. Mohamed I, et al. Among authors: hashimoto y. Proc (Bayl Univ Med Cent). 2024 Oct 10;38(1):63-68. doi: 10.1080/08998280.2024.2406710. eCollection 2025. Proc (Bayl Univ Med Cent). 2024. PMID: 39712406 Free PMC article.
5,346 results